What is lipedema? Symptoms, diagnosis and care options
Lipedema is a chronic, painful disease of the fat tissue in the limbs. What the 2024 S2k guideline and the LWA consensus say about symptoms, diagnosis and care.

Key facts
- Lipedema is a chronic disease with symmetrical, disproportionate fat in the limbs and pain or discomfort.
- It affects almost exclusively women, and hormonal changes may trigger or worsen the symptoms.
- The diagnosis is clinical. No imaging, blood or genetic test is officially approved to confirm it.
- How many women are affected is unknown. Published estimates range from under 1% to 12%.
- ICD-11 lists the condition under code EF02.2.
This article explains what lipedema is, who it affects, how it is diagnosed and which care options the current guidelines describe.
What is lipedema?
Lipedema is a chronic disease of the fat tissue under the skin. In the words of the LWA Delphi consensus, untreated lipedema “typically presents as symmetrical, bilateral enlargement of subcutaneous adipose tissue in the extremities, accompanied by pain and/or discomfort” [1].
The consensus describes this enlargement as disproportionate: the limbs are affected more than the torso. The arms can be involved, and hands and feet are typically spared [1].
The German S2k guideline of 2024 calls lipedema a chronic, painful disease that can restrict quality of life [2]. Its long text treats pain as part of the definition. A symmetrical, disproportionate fat distribution without pain is called lipohypertrophy and is outside the scope of the guideline [3].
What are the typical symptoms?
The leading symptoms are pain and increased sensitivity in the enlarged areas. The consensus lists these features as typical [1]:
- sensitivity to pressure or stretch, mainly reported as pain, and limited to the enlarged areas
- swelling or a feeling of heaviness
- easy bruising in the affected areas
- usually no pitting edema, meaning a pressed fingertip does not leave a lasting dent
- a Kaposi-Stemmer sign that is usually negative
The S2k guideline notes that pain does not correlate with the degree of disproportion [2]. Lipedema can also affect mental health and quality of life. The consensus states that psychological strain, if present, may be caused by the symptoms rather than being their cause [1].
Who is affected?
Lipedema affects almost exclusively women. Reviews and the US standard of care describe onset around hormonal changes such as puberty, pregnancy and menopause [4, 5, 6, 7].
The consensus puts it this way: “Lipedema primarily affects biological females. Occurrence in biological males appears to be possible but rare” [1]. It also states that hormonal changes may trigger or exacerbate the symptoms, and that lipedema is hereditary in some cases [1].
How common is lipedema?
Nobody knows the exact figure. The LWA consensus states that the prevalence in adult women “remains unknown” and that estimates range from less than 1% to up to 12% [1].
The range is wide because studies counted in very different ways:
- Child and colleagues found 67 cases in 15 years at one UK clinic, a minimum prevalence of 1 in 72,000. They called this a significant underestimate because of misdiagnosis and missed referral [4].
- The often quoted figure of up to 11% goes back, as cited by Buso and colleagues, to Földi’s observations among women and girls admitted for swelling of the legs. That is a selected clinic population, not a population survey [6].
- Marshall and Schwahn-Schreiber examined 62 working women in Germany. Counting every stage including mild findings, 39% were affected. Counting only moderate to marked findings, the figure was 9.7% [8].
No large population study has used one validated definition, clinic samples over-represent people who seek care, and lipedema is often confused with obesity and lymphedema [4, 6, 8].
How is lipedema diagnosed?
Lipedema is diagnosed clinically. The consensus states that the diagnosis relies on the medical history, a physical examination and the exclusion of other conditions, and that no imaging, serological or genetic test is officially approved to verify it [1].
Measurements still matter. The consensus recommends standardised measurements such as the waist-to-height ratio (WHtR), the waist-to-hip ratio and the body mass index (BMI) [1]. The S2k guideline asks for weight, height, and waist and hip circumference at the first visit and at follow-up. It notes that BMI alone is not conclusive in lipedema, because fat in the limbs raises the value [2].
Stages describe how the limbs look, not how severe the disease is. The S2k guideline states, with 100% consensus, that morphological stages shall not be used to measure severity [2].
Which conditions need to be ruled out?
The most frequent confusions are with obesity and lymphedema. Obesity often occurs together with lipedema, but the consensus states that lipedema is not an obesity-related comorbidity [1]. Lymphedema involves the feet and shows a positive Stemmer sign, which uncomplicated lipedema usually does not [4]. Our article on telling lipedema, lymphedema and obesity apart explains the differences.
What care options exist?
Current treatments aim to relieve symptoms. The consensus states that all therapeutic interventions “aim at alleviating symptoms and preventing or delaying progression” and calls for a multidisciplinary approach tailored to individual needs [1].
The guideline and the consensus describe these options:
- Conservative care. The S2k guideline covers compression, movement and exercise, weight management, psychosocial support and self-management [2]. The consensus states that conservative management should include lifestyle and nutritional optimisation, compression therapy and exercise [1].
- Surgery. The consensus states that lymph vessel-sparing lipedema reduction surgery should be considered when it may improve symptoms, performed by providers with extensive knowledge of lipedema as part of an integral approach [1]. The S2k guideline stresses that liposuction is not a weight-loss method [2].
- Medication. According to the consensus, there is currently no evidence for the effectiveness of any drug treatment for lipedema [1].
Access to care differs between countries. In Germany, the Federal Joint Committee (G-BA) decided in July 2025 to include liposuction for lipedema in the services of statutory health insurance, with conditions such as six months of conservative therapy and a relatively stable weight [9]. Which option suits you is a decision to make with a specialist.
Is lipedema recognised in the ICD?
Yes. The WHO classification ICD-11, adopted in 2019, lists the condition as EF02.2 Lipoedema [10]. ICD-11 came into effect on 1 January 2022, and each country decides when to use it. The older ICD-10 has no specific code, although the German version ICD-10-GM contains lipedema codes [10].
Where can I find help?
The first step is an examination by a doctor who knows lipedema. If you recognise these symptoms, talk to a specialist about the diagnosis and the options that fit your situation.
Patient organisations have a recognised place in lipedema care and research. The consensus calls collaboration between patients, researchers, clinicians and advocacy groups “crucial for advancing knowledge”, and the experts who took part included patient representatives from seven countries [1]. Our members page shows the LWA network, and our patient page explains how to look for specialist care.
This article was prepared for the LWA website relaunch and is awaiting medical review by the LWA board.
Questions and answers
Is lipedema the same as being overweight?
Can men have lipedema?
Is there a test that confirms lipedema?
Does lipedema always get worse over time?
Sources
- Kruppa P, Crescenzi R, Faerber G, et al. Lipedema World Alliance Delphi consensus-based position paper on the definition and management of lipedema: results from the 2023 Lipedema World Congress in Potsdam. Nat Commun. 2026;17:427. doi:10.1038/s41467-025-68232-z doi.org/10.1038/s41467-025-68232-z
- Faerber G, Cornely M, Daubert C, et al. S2k guideline lipedema. J Dtsch Dermatol Ges. 2024;22(9):1303-1315. doi:10.1111/ddg.15513 doi.org/10.1111/ddg.15513
- Deutsche Gesellschaft für Phlebologie und Lymphologie. S2k-Leitlinie Lipödem. AWMF 037-012, version 5.0. 2024. register.awmf.org/de/leitlinien/detail/037-012
- Child AH, Gordon KD, Sharpe P, et al. Lipedema: an inherited condition. Am J Med Genet A. 2010;152A(4):970-976. doi:10.1002/ajmg.a.33313 doi.org/10.1002/ajmg.a.33313
- Buck DW 2nd, Herbst KL. Lipedema: a relatively common disease with extremely common misconceptions. Plast Reconstr Surg Glob Open. 2016;4(9):e1043. doi:10.1097/GOX.0000000000001043 doi.org/10.1097/GOX.0000000000001043
- Buso G, Depairon M, Tomson D, et al. Lipedema: a call to action! Obesity (Silver Spring). 2019;27(10):1567-1576. doi:10.1002/oby.22597 doi.org/10.1002/oby.22597
- Herbst KL, Kahn LA, Iker E, et al. Standard of care for lipedema in the United States. Phlebology. 2021;36(10):779-796. doi:10.1177/02683555211015887 doi.org/10.1177/02683555211015887
- Marshall M, Schwahn-Schreiber C. Prävalenz des Lipödems bei berufstätigen Frauen in Deutschland (Lipödem-3-Studie). Phlebologie. 2011;40(3):127-134. doi:10.1055/s-0037-1621766 doi.org/10.1055/s-0037-1621766
- Lipedema World Alliance. Great news for women in Germany on health insurance funded lipedema liposuction. 18 July 2025. lipedemaworldalliance.com/great-news-for-women-in-germany-on-health-insurance-funded-lipedema-liposuction/
- Lipedema Foundation. ICD (diagnosis) codes. Accessed 5 November 2026. www.lipedema.org/icd-codes
This article is general information and does not replace a consultation with a physician. If you think you may have lipedema, please talk to a specialist in phlebology, lymphology, angiology or plastic surgery.


